普樂沙福
PLERIXAFOR;MOZOBIL PLERIXAFOR;1,1'-[1,4-Phenylenebis(methylene)]bis-1,4,8,11-tetraazacyclotetradecane;1,4,8,11-Tetraazacyclotetradecane, 1,1'-(1,4-phenylenebis(methylene))bis-;Mozobil;Sdz sid 791;Unii-S915p5499n;1-[[4-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl]methyl]-1,4,8,11-tetrazacyclotetradecane;Plerixafor(AMD3100);1,4-Bis((1,4,8,11-tetraazacyclotetradecan-1-yl)methyl)benzene;AMD 3100; AMD310;AMD-3100;JM 3100;JM-3100;AMD3100 (Plerixafor);Plerixafor (AMD3100);Plerixafor;1,4-bis((1,4,8,11-tetraazacyclotetradecan-1-yl)methyl)benzene octahydrochloride;Plerixafor octahydrochloride;1-{[4-(1,4,8,11-tetraazacyclotetradecan-1-ylmethyl)phenyl]methyl}-1,4,8,11-tetraazacyclotetradecane;1,1'-[1,4-Phenylenebis(methylene)]bis[1,4,8,11-tetraazacyclotetradecane];1,4,8,11-tetraazacyclotetradecanyl[4-(1,4,8,11-tetraazacyclotetradecanylmethyl)phenyl]methane;1,1'-[1,4-Phenylenebis(methylene)]bis[1,4,8,11-tetraazacyclotetradecane] & Hippeastrum hybrid agglutinin( HHA);HY-10046;YIQPUIGJQJDJOS-UHFFFAOYSA-N;DB06809;1,1'[1,4-phenylene-bis-(methylene)]-bis-1,4,8,11-tetraazacyclotetradecane;Plerixafor [USAN:INN:BAN];Plerixafor [USAN];Amd 3100;CS-0451;PLERIXAFOR [MI];AB01566900_01;BRD-K33240821-367-01-8;SR-01000941593;AS-42504;1,1'-(1,4-Phenylenebismethylene)bis(1,4,8,11-tetraazacyclotetradecane);Plerixafor hydrochloride;J-503718;1,1'-(1,4-phenylenebis(methylene))bis(1,4,8,11-tetraazacyclotetradecane);PLERIXAFOR [WHO-DD];Q905835;DTXSID70869520;FT-0660392;CHEMBL18442;PLERIXAFOR [JAN];1,1'-(1,4-PHENYLENEBIS(METHYLENE))BIS-1,4,8,11-TETRAAZACYCLOTETRADECANE;1,1'-{1,4-phenylenebis(methylene)}-bis{1,4,8,11-tetraaza-cyclotetradecane};A809618;11-{4-[4,8, 11-1,4,8,11tetraaza-cyclotetradec-1-ylmethyl]-benzyl}-1,4,8,11tetraaza-cyclotetradecane-1,4,8-tricarboxylic acid tri-tert-butyl ester;NCGC00165722-02;JM 2987;EN300-187119;plerixaforum;JKL 169;CCG-269710;PLERIXAFOR (MART.);1,1'-[1,4-Phenylenebis(methylene)]bis[1,4,8,11-tetraazacyclotetradecane] & Galanthus nivalis agglutinin (GNA);1,1'-[1,4-phenylenebis(methylene)]bis(1,4,8,11-tetraazacyclotetradecane);PLERIXAFOR [ORANGE BOOK];NSC-761388;bicyclam JM-2987;PLERIXAFOR [MART.];NSC761388;EX-A1762;S915P5499N;CHEBI:125354;SR-01000941593-1;s8030;SID791;AC-26837;Z1889837352;L03AX16;AMD3100;PLERIXAFOR [INN];GTPL844;SY042073;plerixafor (amd3100);JM3100;NSC754363;BCPP000104;Plerixafor (JAN/USAN/INN);A25446;NSC-754363;D08971;SDZ SID 791;DTXCID60817494;GNA & AMD-3100;1-({4-[(1,4,8,11-tetraazacyclotetradecan-1-yl)methyl]phenyl}methyl)-1,4,8,11-tetraazacyclotetradecane;Mozobil (TN);NCGC00165722-01;P2678;1-((4-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl)methyl)-1,4,8,11-tetrazacyclotetradecane;L000104;UNII-S915P5499N;SCHEMBL19038;AMD-3100 (CXCR4);1,1'-(1,4-phenylenebis-(methylene))-bis-1,4,8,11-tetraazacyclotetradecane;HHA & AMD-3100;PLERIXAFOR [EMA EPAR];AKOS005266706;NCGC00165722-03;11''''-xylyl bis-1,4,8,11-t...